Punctal occlusion in tear deficiency syndromes

Area of Science:

• Ophthalmology
• Ocular Surface Disease

Background:

• Severe tear deficiency syndromes can significantly impact ocular health and patient quality of life.
• Conditions such as keratoconjunctivitis sicca, Stevens-Johnson syndrome, congenital alacremia, and post-traumatic tear deficiency present challenges in management.
• Current treatments may not always provide adequate relief or may require frequent application.

Purpose of the Study:

• To evaluate the safety and efficacy of punctal occlusion in managing severe tear deficiency syndromes.
• To assess subjective and objective improvements in patients undergoing punctal occlusion.
• To determine the impact of punctal occlusion on the need for artificial tear supplementation.

Main Methods:

• Punctal occlusion was performed on 32 eyes diagnosed with various tear deficiency syndromes.
• Preoperative Schirmer tear test values were recorded but did not influence the decision for occlusion.
• Subjective symptom reporting and objective clinical signs (corneal ulceration, filamentary keratitis, superficial punctate keratitis) were monitored post-procedure.

Main Results:

• Subjective symptomatic improvement was reported in 97% of treated eyes.
• Objective improvement or resolution of corneal signs was observed in 100% of patients.
• Artificial tear use was discontinued or reduced in 85% of eyes post-occlusion.
• Epiphora was not a significant complication, even in patients with initially higher tear production.

Conclusions:

• Punctal occlusion is a safe and highly effective treatment for severe tear deficiency syndromes.
• The procedure leads to significant subjective and objective clinical improvements.
• Punctal occlusion can substantially decrease or eliminate the reliance on artificial tears, enhancing patient comfort and compliance.